Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
212M
-
Shares change
-
+7.28M
-
Total reported value, excl. options
-
$964M
-
Value change
-
+$6.33M
-
Put/Call ratio
-
0.36
-
Number of buys
-
141
-
Number of sells
-
-79
-
Price
-
$4.55
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2023
278 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2023.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 212M shares
of 334M outstanding shares and own 63.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (22.1M shares), MHR FUND MANAGEMENT LLC (20M shares), BlackRock Inc. (18.4M shares), STATE STREET CORP (16.7M shares), PERCEPTIVE ADVISORS LLC (12M shares), MILLENNIUM MANAGEMENT LLC (7.82M shares), Pictet Asset Management Holding SA (6.91M shares), Avoro Capital Advisors LLC (6.7M shares), Artisan Partners Limited Partnership (5.04M shares), and GEODE CAPITAL MANAGEMENT, LLC (4.75M shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.